Aeonx Digital Technology Ltd — Important, 06-02-2026: Company Update

Wanbury Ltd's board has approved the financial results for the quarter and nine months ended 31 December. The company reported total revenue of 162.45 Cr for the quarter and 485.69 Cr for the nine-month period. Net profit stood at 15.76 Cr for the quarter and 44.43 Cr for the nine months. Wanbury operates solely in pharmaceuticals, with two USFDA-approved facilities. The company also issued 15,000 equity shares under an ESOP scheme, increasing share capital by 0.0015 Cr and securities premium by 0.00648 Cr. Management anticipates no significant impact from new labor codes on its financials.